![Vimal Mehta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vimal Mehta
Fondateur chez
BIOXCEL THERAPEUTICS, INC.
Fortune : 81 832 $ au 31/05/2026
Profil
Vimal D.
Mehta is the founder of BioXcel Corp., founded in 2005, serving as Chairman & Chief Executive Officer since 2014.
Dr. Mehta is the founder of BioXcel Therapeutics, Inc., founded in 2017, serving as President, Chief Executive Officer & Director since 2021.
Former jobs include Director at Invea Therapeutics, Inc., Manager-Business Development at CuraGen Corp.
from 1996 to 2002, Senior Vice President-Business Development at Alfasigma UK Ltd. from 2002 to 2006, Assistant Professor at The University of Texas Southwestern Medical Center from 1989 to 1996, and Senior Vice President-Business Development at Jubilant Life Sciences (USA), Inc. from 2006 to 2007.
Education includes a doctorate from the University of Delhi.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/06/2026 | 69 942 ( 0,48 % ) | 81 832 $ | 31/05/2026 |
Postes actifs de Vimal Mehta
| Sociétés | Poste | Début |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Fondateur | 29/03/2017 |
BioXcel Corp.
 BioXcel Corp. Data Processing ServicesTechnology Services Provides pharma data analytics solutions | Directeur Général | 01/01/2005 |
Anciens postes connus de Vimal Mehta
| Sociétés | Poste | Fin |
|---|---|---|
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs | Directeur/Membre du Conseil | 01/01/2023 |
Jubilant Life Sciences (USA), Inc.
 Jubilant Life Sciences (USA), Inc. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Corporate Officer/Principal | 01/01/2007 |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services | Corporate Officer/Principal | 01/01/2006 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Corporate Officer/Principal | 01/01/2002 |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1996 |
Formation de Vimal Mehta
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Galapagos Biotech Ltd.
Galapagos Biotech Ltd. BiotechnologyHealth Technology Operates as a drug discovery company which provides discovery technologies and services | Health Technology |
University of Delhi
 University of Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jubilant Life Sciences (USA), Inc.
Jubilant Life Sciences (USA), Inc. Medical DistributorsDistribution Services Wholesales pharmaceuticals | Distribution Services |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services Provides pharma data analytics solutions | Technology Services |
BioXcel Therapeutics, Inc.
 BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or IMIDs | Health Technology |
Choisissez Zonebourse 
